Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurological Research

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/016164111X12881719352534PMID 21801596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.

  2008cited by this paper
• Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.

  2008cited by this paper
• Mechanisms of ischemic brain damage.

  2008cited by this paper
• Role of endothelin-1 in clinical hypertension: 20 years on.

  2008cited by this paper
• Vascular Permeability Precedes Spontaneous Intracerebral Hemorrhage in Stroke-Prone Spontaneously Hypertensive Rats

  2007cited by this paper
• Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study

  2005cited by this paper
• Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats

  2005cited by this paper
• Inhibition of Both Neutral Endopeptidase and Endothelin-Converting Enzyme by SLV306 Reduces Proteinuria and Urinary Albumin Excretion in Diabetic Rats

  2004cited by this paper
• Analysis of pathological events at the onset of brain damage in stroke‐prone rats: A proteomics and magnetic resonance imaging approach

  2004cited by this paper
• Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure.

  2004cited by this paper
• Impact of the endothelin-A receptor antagonist BQ 610 on microcirculation in global cerebral ischemia and reperfusion.

  2003cited by this paper
• Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats.

  2003cited by this paper
• Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.

  2003cited by this paper
• Vasopeptidase Inhibition: A Double-Edged Sword?

  2003cited by this paper
• Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

  2002cited by this paper
• Classification of endothelin receptors and antagonists in clinical development.

  2002cited by this paper
• Protective Effect of Endothelin Type A Receptor Antagonist on Brain Edema and Injury After Transient Middle Cerebral Artery Occlusion in Rats

  2001cited by this paper
• Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats.

  2000cited by this paper
• Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Hemodynamics and Metabolism in Stroke-Prone Spontaneously Hypertensive Rats before Manifestation of Brain Infarcts

  1999cited by this paper
• Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats.

  1999cited by this paper
• Intraventricular atrial natriuretic peptide for acute intracranial hypertension.

  1997cited by this paper
• Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

  1997cited by this paper
• Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.

  1996cited by this paper
• Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats.

  1996cited by this paper
• The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury

  1995cited by this paper
• Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

  1995cited by this paper
• High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke.

  1994cited by this paper
• Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension.

  1994cited by this paper
• Endothelins: multifunctional renal peptides.

  1993cited by this paper
• Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension

  1992cited by this paper
• Detailed disease processes of cerebral pericytes and astrocytes in stroke-prone SHR.

  1991cited by this paper
• Development of Hypertension and Life Span in Stroke‐Prone Spontaneously Hypertensive Rats During Oral Long‐Term Treatment with Various Antihypertensive Drugs

  1989cited by this paper
• Regional Myocardial Blood Flow in Lambs with Concentric Right Ventricular Hypertrophy

  1974cited by this paper

• Endothelin

  2016cites this paper
• Association of endothelin-converting enzyme-1 polymorphisms with risk of ischemic stroke in the Chinese Han population

  2016cites this paper
• New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?

  2015cites this paper
• New antihypertensive drugs under development.

  2014cites this paper
• Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism.

  2014cites this paper
• Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke

  2014cites this paper
• Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12

  2014cites this paper
• Role of Neprilysin in Various Diseases

  2014cites this paper
• Endothelin receptor antagonists in clinical research--lessons learned from preclinical and clinical kidney studies.

  2014cites this paper
• Effects of Endothelin in Integrated Venous Function in Health and Disease

  2014cites this paper
• Novel tyrosine kinase signaling pathways: implications in vascular remodeling

  2012cites this paper
• Key advances in antihypertensive treatment

  2012cites this paper
• Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives.

  2012cites this paper
• Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme.

  2012influential citation
• Abnormalities in renal dopamine signaling and hypertension : the role of GRK 4 Review

  2011cites this paper